Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 598

1.

Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M; Stomach Cancer Study Group of the Japan Clinical Oncology Group.

Br J Surg. 2014 May;101(6):653-60. doi: 10.1002/bjs.9484. Epub 2014 Mar 25.

PMID:
24668391
2.

A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.

Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, Kawashima Y, Kinoshita T, Terashima M, Nashimoto A, Nakamori M, Onaya H, Sasako M.

Gastric Cancer. 2017 Mar;20(2):322-331. doi: 10.1007/s10120-016-0619-z. Epub 2016 Jun 14.

PMID:
27299887
3.

Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.

Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H.

Eur J Surg Oncol. 2012 Feb;38(2):143-9. doi: 10.1016/j.ejso.2011.11.009. Epub 2011 Dec 9.

PMID:
22154885
4.

Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.

Fushida S, Fujimura T, Oyama K, Kinoshita J, Fujita H, Ninomiya I, Ohta T.

Hepatogastroenterology. 2010 Nov-Dec;57(104):1650-4.

PMID:
21443137
5.

A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.

Katayama H, Ito S, Sano T, Takahari D, Mizusawa J, Boku N, Tsuburaya A, Terashima M, Sasako M; Stomach Cancer Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2012 Jun;42(6):556-9. doi: 10.1093/jjco/hys054. Epub 2012 Apr 23.

PMID:
22525210
6.

Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.

Oyama K, Fushida S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Nakagawara H, Tajima H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Tani T, Fujimura T, Ohta T.

J Surg Oncol. 2012 May;105(6):535-41. doi: 10.1002/jso.22125. Epub 2011 Oct 17.

PMID:
22006649
7.

Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.

Fushida S, Fujimura T, Oyama K, Yagi Y, Kinoshita J, Ohta T.

Anticancer Drugs. 2009 Sep;20(8):752-6. doi: 10.1097/CAD.0b013e32832ec02b.

PMID:
19543076
8.

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

Yoshikawa T, Sasako M, Yamamoto S, Sano T, Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y, Fukushima N.

Br J Surg. 2009 Sep;96(9):1015-22. doi: 10.1002/bjs.6665.

PMID:
19644974
9.

Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer.

Fushida S, Nashimoto A, Fukushima N, Kawachi Y, Fujimura T, Kuwabara S, Musha N; DCS Study Group.

Jpn J Clin Oncol. 2012 Feb;42(2):131-3. doi: 10.1093/jjco/hyr183. Epub 2011 Dec 13.

10.

A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.

Okabe H, Hata H, Ueda S, Zaima M, Tokuka A, Yoshimura T, Ota S, Kinjo Y, Yoshimura K, Sakai Y; Kyoto University Surgical Oncology Group (KUSOG).

J Surg Oncol. 2016 Jan;113(1):36-41. doi: 10.1002/jso.24096. Epub 2015 Nov 25.

PMID:
26604064
11.

[Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].

Yabusaki H, Nashimoto A, Tanaka O.

Gan To Kagaku Ryoho. 2003 Nov;30(12):1933-40. Japanese.

PMID:
14650962
12.

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.

Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97. doi: 10.1007/s00280-013-2073-5. Epub 2013 Jan 22.

PMID:
23338051
13.

[Highly advanced gastric cancer that responded to neoadjuvant combination chemotherapy with docetaxel/CDDP/S-1 (DCS)].

Egawa T, Kenmochi T, Ohashi M, Irino T, Mihara K, Okamura A, Inaba Y, Ito Y, Hayashi S, Nagashima A.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2470-2. Japanese.

PMID:
21224609
14.

[A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1].

Yasui T, Mukubo H, Sato N, Kita I, Fushida S.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2229-31. Japanese.

PMID:
24394068
15.

A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).

Kataoka K, Tokunaga M, Mizusawa J, Machida N, Katayama H, Shitara K, Tomita T, Nakamura K, Boku N, Sano T, Terashima M, Sasako M; Stomach Cancer Study Group/Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2015 Nov;45(11):1082-6. doi: 10.1093/jjco/hyv134. Epub 2015 Sep 9.

PMID:
26355164
16.

[Urgent gastrectomy in a patient who developed perforated gastric cancer during preoperative chemotherapy with S-1 plus cisplatin].

Okabe Y, Yajima K, Ishikawa T, Kosugi S, Sakamoto K, Sato Y, Kanda T, Wakai T.

Gan To Kagaku Ryoho. 2014 Jan;41(1):95-8. Review. Japanese.

PMID:
24423960
17.
18.

[A case of advanced gastric cancer exhibiting pathological complete response after neoadjuvant chemotherapy].

Taniguchi M, Watanabe Y, Shirakawa M, Nakano H, Endo W, Hamano R, Tsujie M, Yano H.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2298-300. Japanese.

PMID:
24394091
19.

Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.

Kunisaki C, Makino H, Kimura J, Takagawa R, Kanazawa A, Ota M, Kosaka T, Ono HA, Akiyama H, Endo I.

Oncology. 2015;88(5):281-8. doi: 10.1159/000369497. Epub 2015 Jan 14.

PMID:
25591954
20.

A preliminary study of preoperative chemotherapy combining irinotecan and cisplatin in patients with gastric cancer with unresectable para-aortic lymph node metastases.

Yamao T, Ohta K, Ohyama S, Ishihara S, Chin K, Maruyama M, Takahashi T, Nakajima T.

Jpn J Clin Oncol. 2004 May;34(5):255-61.

PMID:
15231860

Supplemental Content

Support Center